The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Doxercalciferol · DOXERCALCIFEROL 4 ug/2mL · Injection, Solution · Intravenous · Gland Pharma Limited
NDC 68083-0359-50 · 50 VIAL, MULTI-DOSE in 1 CARTON / 2 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Eugia US LLC | DOXERCALCIFEROL 4 ug/2mL | Jul 15, 2026 | Sep 3, 2026 |
| Alembic Pharmaceuticals Inc. | DOXERCALCIFEROL 4 ug/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | DOXERCALCIFEROL 2 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | DOXERCALCIFEROL 4 ug/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | DOXERCALCIFEROL 4 ug/2mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Doxercalciferol — NDC 68083-0359-50," retrieved September 3, 2026, https://drugdashboards.com/drug/68083035950.
Free to cite with attribution — see how the data is put together.